About Us
Contact Us
Regulatory
Community
Site Map
Links
Stock Price
Glossary
Investor Relations
Media Gateway
Businesses
Governance
Uranium 101
Careers
Company Profile Why Invest? Events Calendar Management Views Financial Reporting Shareholder Information
PDF
Contact IR
 
TSX:  $17.22 (-0.72)
NYSE:  $13.61 (-0.89)
  15 minute delay
Uranium Price
Print Page
Print Page

Balance Sheets

        (Restated)  
As at December 31 2003     2002  
        (Thousands)  
Assets            
Current Assets            
   Cash $ 84,069   $ 58,096  
   Accounts receivable   181,337     186,369  
  Inventories [note 3]   316,435     339,684  
  Supplies and prepaid expenses   41,571     45,731  
  Current portion of long-term receivables, investments and other [note 5]   54,866     20,163  
   
      678,278     650,043  
             
Property, plant and equipment [note 4]   2,072,156     2,060,250  
Long-term receivables, investments and other [note 5]   608,977     257,523  
 
Total assets $ 3,359,411   $ 2,967,816  
 
Liabilities and Shareholders' Equity            
Current liabilities            
  Accounts payable and accrued liabilities $ 156,112   $ 131,932  
  Dividends payable   11,598     6,998  
  Current portion of long-term debt [note 6]   4,331     6,318  
  Current portion of other liabilities [note 8]   1,563     16,931  
  Future income taxes [note 15]   24,237     9,198  
   
      197,841     171,377  
       
Long-term debt [note 6]   238,707     218,290  
Provision for reclamation [note 7]   150,444     159,344  
Other liabilities [note 8]   36,196     9,523  
Future income taxes [note 15]   501,674     530,625  
   
      1,124,862     1,089,159  
     
Minority interest   14,690     18,078  
   
Shareholders' equity            
  Preferred securities [note 9]   158,022     193,763  
  Convertible debentures [note 10]   226,444     -    
  Share capital [note 11]   708,345     680,934  
  Contributed surplus   474,927     472,488  
  Retained earnings   665,377     494,341  
  Cumulative translation account [note 12]   (13,256)     19,053  
   
      2,219,859     1,860,579  
   
Total liabilities and shareholders' equity $ 3,359,411 $ 2,967,816
 
               
Commitments and contingencies [notes 6,7,18,19,24,25]            
See accompanying notes to consolidated financial statements.            
Approved by the board of directors